IP Library Granted Patent US 10,125,177
Granted Patent B2
US 10,125,177 · App. 15/865,594 · Granted Nov 13, 2018

Treponema pallidum triplet antigen

Inventors: Jian Zheng (Raritan, NJ); Renee Yura (Bridgewater, NJ); Jianping Yang (Tyler, TX)
Assignee: ORTHO-CLINICAL DIAGNOSTICS, INC.
C07K14/20G01N33/56911G01N33/571C07K2319/00C07K2319/40G01N2333/20G01N2800/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,125,177
App. No.
15/865,594
Granted
Nov 13, 2018
Kind
B2
Abstract

A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.

Claims (12)

1. A Treponema pallidum triplet antigen comprising the amino acid sequence as shown in SEQ ID NO:10.

2. The Treponema pallidum triplet antigen of claim 1 labeled with a detectable marker.

3. The Treponema pallidum triplet antigen of claim 2 wherein the detectable marker is horseradish peroxidase.

4. A kit for detection of Treponema pallidum antibodies, the kit comprising:

the Treponema pallidum triplet antigen of claim 1 ; and

a second Treponema pallidum triplet antigen of claim 1 , the second Treponema pallidum triplet antigen labeled with a detectable marker.

5. The kit of claim 4 further comprising positive or negative controls.

6. The kit of claim 4 further comprising calibration samples.

7. The kit of claim 4 further comprising one or more of enzyme conjugate, substrate for enzyme conjugate, buffer solution, and washing solution.

8. A method of detecting the presence of Treponema pallidum antibodies in a sample, the method comprising:

contacting the sample with a first antigen which is immobilized on a solid support and which comprises the Treponema pallidum triplet antigen of claim 1 , wherein Treponema pallidum antibodies present in the sample bind to the Treponema pallidum triplet antigen forming an antibody/antigen complex; and

detecting the antibody/antigen complex, thereby detecting the presence of Treponema pallidum antibodies.

Assignments (6)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SUPPLEMENTAL SECURITY AGREEMENT Recorded Jan 29, 2020
From: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC
Reel/Frame 051736/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2018
From: ZHENG, JIAN; YURA, RENEE; YANG, JIANPING
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 045428/0639 →
Continuity (5)
Division 14980200 · Dec 28, 2015
Division 14193530 · Feb 28, 2014
Division 13350235 · Jan 13, 2012
Provisional Application 61432570 · Jan 13, 2011
Related Publication 20180141980A1 · May 24, 2018